| Storage Buffer | PBS pH 7.4 |
| Storage Temperature | -80ºC |
| Shipping Temperature | Dry Ice. Shipping note: Product will be shipped separately from other products purchased in the same order. |
| Purification | Ion-exchange Purified |
| Cite This Product | Human Recombinant Alpha Synuclein Oligomers (StressMarq Biosciences | Victoria, BC CANADA | Catalog# SPR-469) |
| Certificate of Analysis | Certified >95% pure using SDS-PAGE analysis. Low endotoxin <5 EU/mL @ 2mg/mL. |
| Other Relevant Information | Monomer source is catalog# SPR-316. |
| Alternative Names | Alpha-synuclein, Alpha synuclein, Asyn, SNCA, NACP, PARK1, PARK4, PD1, Synuclein alpha, Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor, Synuclein Alpha-140, SYN, Parkinson's disease familial 1 Protein Protein |
| Research Areas | Alzheimer's Disease, Neurodegeneration, Neuroscience, Parkinson's Disease, Synuclein, Tangles & Tau, Multiple System Atrophy |
| Cellular Localization | Cytoplasm, Membrane, Nucleus |
| Accession Number | NP_000336.1 |
| Gene ID | 6622 |
| Swiss Prot | P37840 |
| Scientific Background |
Alpha-synuclein, encoded by the SNCA gene (UniProt ID: P37840), is a presynaptic neuronal protein involved in synaptic vesicle trafficking and neurotransmitter release. Under pathological conditions, alpha-synuclein misfolds and assembles into soluble oligomers—intermediates in the formation of insoluble fibrils found in Lewy bodies, a hallmark of Parkinson’s disease and related synucleinopathies. Alpha-synuclein oligomers are increasingly recognized as the most neurotoxic species in the aggregation cascade. These oligomers disrupt cellular homeostasis by compromising membrane integrity, impairing mitochondrial function, and interfering with protein degradation pathways. Their ability to propagate between neurons in a prion-like fashion contributes to the progressive spread of neurodegeneration. Experimental models using alpha-synuclein oligomers have revealed their role in triggering neuroinflammation, synaptic dysfunction, and selective neuronal loss. These insights have positioned oligomers as critical targets for therapeutic intervention and biomarker development. Epigallocatechin Gallate (EGCG) reduces alpha synuclein fibril formation in favour of spherical soluble oligomers. Due to their structural and functional relevance to human disease, alpha-synuclein oligomers are widely used in preclinical research to evaluate aggregation inhibitors, immunotherapies, and neuroprotective agents. Their application enhances the translational potential of drug discovery efforts aimed at halting or reversing neurodegenerative progression. |
| References |
1. “Genetics Home Reference: SNCA”. US National Library of Medicine. (2013). 2. Zhang L., et al. (2008) Brain Res. 1244: 40-52. 3. Alim M.A., et al. (2002) J Biol Chem. 277(3): 2112-2117. 4. Kokhan V.S., Afanasyeva M.A., Van'kin G. (2012) Behav. Brain. Res. 231(1): 226-230. 5. Spillantini M.G., et al. (1997) Nature. 388(6645): 839-840. 6. Mezey E., et al. (1998) Nat Med. 4(7): 755-757. 7. Ehrnhoefer, D. E. et al. (2008). Nat Struct Mol Biol. 15(6):558-566. |
Reviews
There are no reviews yet.